Four Cycles of CHOP Instead of Six for Favorable DLBCL Four Cycles of CHOP Instead of Six for Favorable DLBCL

Patients with favorable-prognosis DLBCL receiving four cycles of R-CHOP followed by two additional cycles of rituximab had outcomes similar to those in patients receiving six cycles.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news